Literature DB >> 8380021

Toxicity of amphotericin B emulsion formulations.

C Washington, M Lance, S S Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8380021     DOI： 10.1093/jac/31.5.806

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Amphotericin B in lipid emulsion: stability, compatibility, and in vitro antifungal activity.

Authors:  S Walker; S A Tailor; M Lee; L Louie; M Louie; A E Simor
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 2.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Population pharmacokinetics of amphotericin B in children with malignant diseases.

Authors:  C E Nath; A J McLachlan; P J Shaw; R Gunning; J W Earl
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

4.  Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.

Authors:  C E Nath; P J Shaw; R Gunning; A J McLachlan; J W Earl
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.

Authors:  Shalini Asthana; Anil K Jaiswal; Pramod K Gupta; Vivek K Pawar; Anuradha Dube; Manish K Chourasia
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

6.  Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds.

Authors:  R Semis; I Polacheck; E Segal
Journal:  Mycopathologia       Date:  2010-01-13       Impact factor: 2.574
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.